Abstract
Important discoveries and studies that help inform us about the best methods to evaluate and manage children with end-stage renal disease (ESRD) continue to emerge. This review addresses a number of recent publications regarding important clinical issues for children with ESRD. Despite advances made in previous years, many clinical problems remain in the care of the pediatric dialysis patient. This review covers five topics of recent interest: three articles that address important patient outcome measures such as dialysis adequacy and hemoglobin; two articles that address growth failure in a chronic dialysis patients; five articles that address cardiovascular (CV) morbidity, mortality, and interventions to reduce CV risk in children; two articles that address mineral-bone disorder (MBD) and evidence that past strategies for MBD in children may have increased CV disease; and two articles that address nephrogenic systemic fibrosis, a recently described disorder in chronic kidney disease (CKD) patients that occurs in children as well as adults. Using a concise consistent format, each of the 14 key publications is summarized, and the “conclusion” for the practitioner is identified. The goal of this review is to highlight important work done in this area and focus attention on the important issues raised by each article.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
National Kidney Foundation (2006) KDOQI clinical practice guidelines and clinical practice recommendations for 2006 updates: hemodialysis adequacy, peritoneal dialysis adequacy and vascular access. Am J Kidney Dis 48(suppl 1):S1–S322
Goldstein SL, Brem A, Warady BA, Fivush B, Frankenfield D (2006) Comparison of single-pool and equilibrated Kt/V values for pediatric hemodialysis prescription management: analysis from the CMS Clinical Performance Measures Project. Pediatr Nephrol 21:1161–1166
Amaral S, Hwang W, Fivush B, Neu A, Frankenfield D, Furth S (2006) Association of Mortality and Hospitalization with Achievement of Adult Hemoglobin Targets in Adolescents Maintained on Hemodialysis. J Am Soc Nephrol 17:2878–2885
Mahan JD, Warady BS, The Consensus Committee (2006) Assessment and treatment of short statue in pediatric patients with CKD: a consensus statement. Pediatr Nephrol 21:917–930
Fischbach M, Terzic J, Menouer S, Dheu C, Soskin S, Helmstetter A, Burger M-C (2006) Intensified and daily hemodialysis in children might improve statural growth. Pediatr Nephrol 21:1746–1752
Civilibal M, Caliskan S, Adaletli I, Oflaz H, Sever L, Candan C, Canpolat N, Kasapcopur O, Kuruoglu S, Arisoy N (2006) Coronary artery calcifications in children with end-stage renal disease. Pediatr Nephrol 21:1426–1433
Briese S, Wiesner S, Will JC, Lembcke A, Opgen-Rhein B, Nissel R, Wernecke K-D, Andreae J, Haffner D, Querfeld U (2006) Arterial and cardiac disease in young adults with childhood-onset end-stage renal disease – impact of calcium and vitamin D therapy. Nephrol Dial Transplant 21:1906–1914
Mitsnefes MM, Barletta GM, Dresner IG, Chand DH, Geary D, Lin J-J, Patel H (2006) Severe cardiac hypertrophy and long-term dialysis: the Midwest Pediatric Nephrology Consortium study. Pediatr Nephrol 21:1167–1170
Ulinski T, Genty J, Viau C, Tillous-Borde I, Deschênes G (2006) Reduction of left ventricular hypertrophy in children undergoing hemodialysis. Pediatr Nephrol 21:1171–1178
Zwolinska D, Wladyslaw G, Szczepańska M, Kiliś-Pstrusińska K, Szprynger K (2006) Lipid peroxidation and antioxidant enzymes in children on maintenance dialysis. Pediatr Nephrol 21:705–710
Seeherunvong W, Nwobi O, Abitbol CL, Chandar J, Strauss J, Zilleruelo G (2006) Paricalcitol versus calcitriol treatment for hyperparathyroidism in pediatric hemodialysis patients. Pediatr Nephrol 21:1434–1439
Klaus G, Watson A, Edefonti A, Fischbach M, Ronnholm K, Schaefer F, Simkova E, Stefanidis CJ, Strazdins V, Vande Walle J, Schroder C, Zurowska A, Ekim M (2006) Prevention and treatment of renal osteodystrophy in children on chronic renal failure: European guidelines. Pediatr Nephrol 21:151–159
Auron A, Shao L, Warady BA (2006) Nephrogenic fibrosing dermopathy in children. Pediatr Nephrol 21:1307–1311
DiCarlo JB, Gupta EA, Solomon AR (2006) A pediatric case of nephrogenic fibrosing dermopathy: Improvement after combination therapy. J Am Acad Dermatol 54:914–916
Guirguis-Blake J, Calonge N, Miller T, Siu A, Teutsch S, Whitlock E (2007) Current processes of the U.S. Preventive Services Task Force: refining evidence-based recommendation development. Ann Intern Med 147:117–122
Barton MB, Miller T, Wolff T (2007) How to read the new recommendation statement: methods update from the U.S. Preventive Services Task Force. Ann Intern Med 147:123–127
National Kidney Foundation (2005) K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Children with Chronic Kidney Disease. Am J Kidney Dis 46 (Suppl 1):S1–S121
Acknowledgements
Presented in part at the 28th Annual Dialysis Conference in Denver, CO, USA, on 20 Feb 2007
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mahan, J.D., Patel, H.P. Recent advances in pediatric dialysis: a review of selected articles. Pediatr Nephrol 23, 1737–1747 (2008). https://doi.org/10.1007/s00467-008-0825-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00467-008-0825-y